Infectious Diseases (except HIV/AIDS)
Showing page 233 of 716 pages of list content
-
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
This article's authors -
Integrin/TGF-β1 inhibitor GLPG-0187 blocks SARS-CoV-2 Delta and Omicron pseudovirus infection of airway epithelial cells which could attenuate disease severity
This article's authors -
Predicting COVID-19 severity using major risk factors and received vaccines
This article's authors -
Magnitude and breadth of neutralizing antibody responses elicited by SARS-CoV-2 infection or vaccination
This article's authors -
COVIDFast™: A high-throughput and RNA extraction-free method for SARS-CoV-2 detection in swab (SwabFAST™) or saliva (SalivaFAST™)
This article's authors -
Head-to-head comparison of nasal and nasopharyngeal sampling using SARS-CoV-2 rapid antigen testing in Lesotho
This article's authors -
Global Perspective of COVID-19 Vaccine Nationalism
This article's authors -
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
This article's authors -
Antibody binding and ACE2 binding inhibition is significantly reduced for the Omicron variant compared to all other variants of concern
This article's authors -
Predicting the impact of COVID-19 vaccination campaigns – a flexible age-dependent, spatially-stratified predictive model, accounting for multiple viral variants and vaccines
This article's authors